These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 30838457)

  • 41. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs).
    Hyttel J
    Int Clin Psychopharmacol; 1994 Mar; 9 Suppl 1():19-26. PubMed ID: 8021435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.
    Waldinger MD; Hengeveld MW; Zwinderman AH; Olivier B
    J Clin Psychopharmacol; 1998 Aug; 18(4):274-81. PubMed ID: 9690692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths.
    Cao TXD; Filliter C; Montastruc F; Yu OHY; Fergusson E; Rej S; Azoulay L; Renoux C
    J Affect Disord; 2022 Dec; 318():231-237. PubMed ID: 36084758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New-Generation, Non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIs.
    Mandrioli R; Protti M; Mercolini L
    Curr Med Chem; 2018; 25(7):772-792. PubMed ID: 28707591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective serotonin reuptake inhibitors in major depression disorder treatment: an umbrella review on systematic reviews.
    Ghaffari Darab M; Hedayati A; Khorasani E; Bayati M; Keshavarz K
    Int J Psychiatry Clin Pract; 2020 Nov; 24(4):357-370. PubMed ID: 32667275
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update.
    Hemeryck A; Belpaire FM
    Curr Drug Metab; 2002 Feb; 3(1):13-37. PubMed ID: 11876575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test.
    Redrobe JP; Bourin M
    Psychopharmacology (Berl); 1998 Jul; 138(2):198-206. PubMed ID: 9718290
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
    Hirano K; Kimura R; Sugimoto Y; Yamada J; Uchida S; Kato Y; Hashimoto H; Yamada S
    Br J Pharmacol; 2005 Mar; 144(5):695-702. PubMed ID: 15678084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.
    Cryan JF; O'Leary OF; Jin SH; Friedland JC; Ouyang M; Hirsch BR; Page ME; Dalvi A; Thomas SA; Lucki I
    Proc Natl Acad Sci U S A; 2004 May; 101(21):8186-91. PubMed ID: 15148402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients.
    Shih YC; Bekele NB; Xu Y
    Pharmacoeconomics; 2007; 25(10):843-62. PubMed ID: 17887806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea.
    DeVane CL
    J Clin Psychiatry; 2003; 64 Suppl 18():14-9. PubMed ID: 14700450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pharmacokinetics of SSRI antidepressants: half-life and clinical applicability].
    Gury C; Cousin F
    Encephale; 1999; 25(5):470-6. PubMed ID: 10598311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors.
    DeVane CL
    Cell Mol Neurobiol; 1999 Aug; 19(4):443-66. PubMed ID: 10379420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Some aspects of genetic polymorphism in the biotransformation of antidepressants.
    Brøsen K
    Therapie; 2004; 59(1):5-12. PubMed ID: 15199661
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Use of antidepressant drugs in schizophrenic patients with depression].
    Micallef J; Fakra E; Blin O
    Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expenditures.
    Dewa CS; Hoch JS; Goering P
    Clin Ther; 2001 Feb; 23(2):292-306. PubMed ID: 11293562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.
    Owens MJ; Knight DL; Nemeroff CB
    Biol Psychiatry; 2001 Sep; 50(5):345-50. PubMed ID: 11543737
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Block of volume-regulated anion channels by selective serotonin reuptake inhibitors.
    Maertens C; Droogmans G; Verbesselt R; Nilius B
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):158-65. PubMed ID: 12122503
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function.
    Hodge JM; Wang Y; Berk M; Collier FM; Fernandes TJ; Constable MJ; Pasco JA; Dodd S; Nicholson GC; Kennedy RL; Williams LJ
    Biol Psychiatry; 2013 Jul; 74(1):32-9. PubMed ID: 23260229
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New antidepressants: use in high-risk patients.
    Hale AS
    J Clin Psychiatry; 1993 Aug; 54 Suppl():61-70; discussion 71-3. PubMed ID: 8253707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.